AUTHOR=Xu Bei , Wang Xin , Guo Jifeng , Xu Huizhuo , Tang Beisha , Jiao Bin , Shen Lu 

TITLE=Retinal Microvascular Density Was Associated With the Clinical Progression of Parkinson’s Disease

JOURNAL=Frontiers in Aging Neuroscience

VOLUME=14

YEAR=2022

URL=https://www.frontiersin.org/journals/aging-neuroscience/articles/10.3389/fnagi.2022.818597

DOI=10.3389/fnagi.2022.818597

ISSN=1663-4365

ABSTRACT=<sec><title>Background</title><p>Retinal microvascular density has been studied in neurodegenerative diseases, whereas patients with Parkinson’s disease (PD) at different clinical stages have been rarely investigated. The present study aimed to evaluate the microvascular variations in superficial retinal capillary plexus (SCP) in patients with PD on different Hoehn-Yahr (H-Y) stages by optical coherence tomography angiography (OCTA), as well as determine their relationships with clinical parameters.</p></sec><sec><title>Methods</title><p>In total, 115 patients with PD and 67 healthy controls (HCs) were recruited. The PD group was divided into three groups based on the H-Y stage. The OCTA examination was performed in all participants, and the macular vessel density (m-VD), peripapillary vessel density (p-VD), and foveal avascular zone (FAZ) area were measured.</p></sec><sec><title>Results</title><p>The m-VD in all regions, p-VD in center [6.1 (4.8, 6.95) mm<sup>–1</sup> in healthy eyes vs. 5.1 (3.7, 6.4) mm<sup>–1</sup> in patients], nasal inner (NI) [18.5 (17.8, 19.3) mm<sup>–1</sup> in healthy eyes vs. 17.9 (17.1, 18.7) mm<sup>–1</sup> in patients], temporal outer (TO) [19.6 (18.9, 20.2) mm<sup>–1</sup> in healthy eyes vs. 19.3 (18.5, 19.7) mm<sup>–1</sup> in patients] regions and FAZ area [0.36 (0.32, 0.39) mm<sup>2</sup> in healthy eyes vs. 0.29 (0.26, 0.33) mm<sup>2</sup> in patients] noticeably decreased in PD groups compared with HC (<italic>p</italic> &lt; 0.05). Moreover, the FAZ area was suggested to decline significantly in patients with PD with H-Y I stage (<italic>p</italic> &lt; 0.05), while it was more serious in the H-Y III stage in patients. Furthermore, we found that m-VD exhibited a significant negative correlation with age, disease duration, UPDRS scores, NMSS scores, and H-Y stage.</p></sec><sec><title>Conclusion</title><p>OCTA has the potential to non-invasively detect the microvascular changes in patients with PD with different clinical stages <italic>in vivo</italic>, and it may be a valuable tool to monitor the PD progression.</p></sec>